SARS-CoV-2 Antigen Rapid Test (Colloidal Goridhe) yekuzviedza iwe pachako inoitirwa kuongororwa kwemhando yeSARS-CoV-2 Antigen (Nucleocapsid protein) mumasamples emunhu mu vitro.
1. kuongororwa kwehuwandu hwevanhu, sechipatara, airport, chiteshi, nharaunda, nezvimwe.
2. kutariswa kwenguva pfupi kunoramba kuripo.
* Anterior nasal swab specimen, isingasviki
* Yakanyanya nyore kushandisa
* Yakanaka, hapana chiridzwa chinodiwa
* Nekukurumidza, mhedzisiro mukati me15 ~ 20 maminetsi
* Mari-inoshanda
Iyo SARS-CoV-2 hutachiona chidimbu inoumbwa nezvikamu zvishanu: RNA gene cheni uye mana mapuroteni. Iro rekunze rechikamu iSpike Protein (S), uye Viral Envelope iri pazasi peSpike inoumbwa neEmvuropu Protein (E) uye Membrane Protein (M). Iyo yakakosha iri mukati mehamvuropu ndeye helical yakapetwa chimiro chinoumbwa neRNA gene cheni uye Nucleocapsid mapuroteni (N). Uchishandisa musimboti wekusunga chaiko kweantigen uye antibody, kuvapo kweSARS-CoV-2 antigen (Nucleocapsid protein) inogona kuwonekwa neanorwisa matutu.
Zvakanakira pamusoro paElisa uye PCR
Nzira | ELISA Kit | RT-PCR | Colloidal Gold Test Kit (Colloidal Gold) |
Mutengo Wezviridzwa | Zvinodhura | Zvinodhura | Cheap |
Nguva yekuona | Yakareba | Yakareba | Pfupi |
Amplification Zvakananga |
Yakasimba | Yakasimba | Yakasimba |
Environmental Zvinodiwa |
High | High | Low |
Operation Dambudziko |
High | High | Low |
Kuita kweSARS-CoV-2 Antigen Rapid Test (Colloidal Goridhe) yakavambwa iine mazana masere nemakumi mashanu nematatu emhando dzakaunganidzwa kubva kuvarwere vane zviratidzo vaifungidzirwa kuti vane COVID-19. Anterior nasal swab specimens akaunganidzwa uye akaedzwa maererano nezvinodiwa zveMirairo Yekushandisa. Kuchengetwa, kutakurwa uye kucherechedzwa kwemasampuli mushure mekuunganidzwa kwakasangana nezvinodiwa zveMirairo Yekushandisa. Panguva imwecheteyo, SARS-CoV-2 yakaonekwa ne emergency nucleic acid yekuona reagent.
Clinical performance pfupiso yeWIZ'S SARS-CoV-2 Antigen Rapid Test (Colloidal Gold)
Test Results | Reference PCR Mibairo | ||
Positive | Negative | Total | |
Positive | 328 | 0 | 328 |
Negative | 14 | 517 | 531 |
Total | 342 | 517 | 859 |
PPA: 95.91% (C.I. 93.25% ~ 97.55%)
NPA: 100.00% (C.I. 99.26% ~ 100.00%)
OPA: 98.37% (C.I. 97.28% ~ 99.03%)
Isu, mugadziri, pano, tinozivisa kuti chigadzirwa (s) sezvakatsanangurwa pamusoro zvinosangana nezvinodiwa zveEuropean Directive 98/79/EC pa in vitro Diagnostic Medical Devices. Ese anotsigira magwaro ehunyanzvi anoratidza kutevedzera anochengetwa nemugadziri uye anogona kuitwa kuti awanikwe neMumiriri Akabvumidzwa muEurope.
AIHWA. | Product Name | Sayenzi | Zvinotsanangurwa (T/Kit) |
CE Certification |
1 | SARS-CoV-2 Antigen Rapid Test | nasopharyngeal/oropharyngeal swab specimen collection |
1/2/5/10/20/25 | EHE |
2 | SARS-CoV-2 Antigen Test | nasopharyngeal/oropharyngeal swab specimen collection |
1/2/5/10/20/25 | EHE |
3 | SARS-CoV-2 Antigen Rapid Test (Mate) | Mate | 1/2/5/10/20/25 | EHE |
4 | SARS-CoV-2 Antigen Rapid Test (Colloidal Gold) | nasal swab specimen collection | 1/2/5/10/20/25 | EHE |
5 | SARS-CoV-2 Antigen Rapid Test (Sputum/Mate/Chituru) | Mapfira/Mate/Matsvina | 1/2/5/10/20/25 | EHE |
Kutumira Nzira | Shipping Terms | Area |
Express | TNT /FEDEX/DHL/UPS | Nyika Dzese |
Gungwa | FOB/CIF/CFR/DDU | Nyika Dzese |
Railway | DDP | Nyika dzeEurope |
Ocean +Express | DDP | Europe Nyika / USA / Canada / Australia / Southeast Asia / Middle East |
A: Both.Tanga tiri mundima iyi kweanopfuura 7years.Nezvigadzirwa zvepamusoro zvemhando yepamusoro uye mutengo wemakwikwi, tinotarisira nomwoyo wose kukudziridza bhizinesi rinobatsirana nevatengi vedu pasi rose.
A: T/T,L/C,D/A,D/P zvichingodaro.
A: EXW, FOB, CFR, CIF, DDU uye zvichingodaro.
A: Kazhinji, zvinotora 15 kusvika 30 mazuva mushure mekugamuchira dhipoziti Nguva chaiyo yekuendesa inobva pane zvinhu uye uwandu hwekuraira kwako.
A: Hongu, tinogona kugadzira nemasampuli ako kana hunyanzvi kudhirowa.
A: Kana huwandu hwacho huri hudiki, masampula anove emahara, asi vatengi vanofanirwa kubhadhara mutengo wekutumira.
A: Hongu, tine 100% bvunzo tisati tasvika.
A: Isu tinochengeta kunaka kwakanaka uye mutengo wemakwikwi kuti tive nechokwadi chekuti vatengi vedu vanobatsirwa; uye tinoremekedza mutengi wese seshamwari yedu uye tinoita bhizinesi nemoyo wese uye kuita hushamwari navo.